Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Market Indicators
Chart for Dow Jones Industrial Average (DJI: DJI) Chart for Dow Jones Industrial Average (DJI: DJI)
Index Price Change % Change
DJI DAILY 18,228.30
+133.47
+0.74%
S&P 500  2,168.14
+8.21
+0.38%
Nasdaq DAILY 5,305.71
+48.22
+0.92%
Gold RT 1,326.70
-3.70
-0.28%
Oil RT 46.95
+2.28
+5.10%
10Y Yield DAILY 1.563
+0.01
+0.44%
Sectors
More Sectors
Sector % Change YTD %
Basic Materials Sector 
+2.32%
+22.25%
Conglomerates Sector 
+0.19%
+2.04%
Consumer Goods Sector 
-0.12%
+8.25%
Financial Sector 
+0.22%
+3.41%
Healthcare Sector 
+0.16%
-1.91%
Industrial Goods Sector 
+0.79%
+14.26%
Services Sector 
+0.08%
+4.55%
Technology Sector 
-0.08%
+8.23%
Utilities Sector 
+0.25%
+18.37%
Currencies
More Currencies
flag more Euro to Dollar
1 to 1.1217
 more flag
flag more Dollar to Yen
1 to 100.733
 more flag
flag more GBP to Dollar
1 to 1.3022
 more flag
flag more Dollar to CAD
1 to 1.3119
 more flag
World Markets
More
Index Price Change % Change
flag FTSE 6,849.38
+41.71
+0.61%
flag CAC 4,432.45
+33.77
+0.77%
flag DAX 10,438.34
+76.86
+0.74%
flag NIKKEI 16,465.40
-218.53
-1.31%
flag HSI 23,619.65
+47.75
+0.20%
flag ASX 5,500.20
+6.50
+0.12%
flag S&P/TSX 14,729.38
+171.34
+1.18%
Market Summary
Previous
Wells Fargo CEO to forfeit millions
The markets traded lower during the midday with the Dow losing 23 points to 18,204. Nasdaq fell 13 points to 5,292. Read More
TICKERS  COMP DJI NDX NYA
Stocks
More News
Avis warns of demand weakness
Avis Budget Group Inc. (Nasdaq: CAR) warned of demand weakness in Europe sending the stock price plummeting $3.16 to close at $35.77.... Read More
TICKERS  CAR
Disappointing study results for Ligand and Amgen
Ligand Pharmaceuticals Inc. (Nasdaq: LGND) partner Amgen Inc. (Nasdaq: AMGN) reported disappointing results from a Phase 3 trial of Kyprolis. Shares of Ligand Pharmaceuticals plummeted $13.45 to close... Read More
TICKERS  AMGN LGND
Real Goods Solar benefits from presidential debate
Shares of Real Goods Solar Inc. (Nasdaq: RGSE) more than doubled by leaping $2.94 to close at $5.59 after Senator Hillary Clinton advocated for installing 500 million more solar panels during the... Read More
TICKERS  RGSE
Caesars reaches restructuring agreement
Caesars Entertainment Corp. (Nasdaq: CZR) reached a restructuring agreement with its creditors. The stock price tumbled $1.71 to close at $7.75.... Read More
TICKERS  CZR
Rice Energy prices offering at discount
Rice Energy Inc. (NYSE: RICE) priced its public offering of 40 million common shares at the discounted price of $25.50 per share sending the stock price tumbling $2.14 to close at $25.00.... Read More
TICKERS  RICE
Boston Scientific buys EndoChoice Holdings
Boston Scientific Corp. (NYSE: BSX) will pay a premium of approximately $210 million in cash to acquire EndoChoice Holdings Inc. (NYSE: GI). Shares of Boston Scientific eased a penny to close at $23.72... Read More
TICKERS  BSX GI
Acorda redemption rights terminated
The redemption rights of Acorda Therapeutics Inc. (Nasdaq: ACOR) regarding Biotie Therapies stock have been terminated. The stock price plummeted $4.29 to close at $22.99.... Read More
TICKERS  ACOR
Pain Therapeutics receives complete response letter
The Food and Drug Administration issued a complete response letter to Pain Therapeutics Inc. (Nasdaq: PTIE) saying that its New Drug Application for Remoxy ER could not be approved in its current form.... Read More
TICKERS  PTIE
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
No Need For Yield Curve Inversion, There Is Already Much Worse Indicated
2
Technically Speaking: Still Not Out Of The Woods
3
Metals at Important Pivot
4
The Federal Reserve Note "Dollar" Is Indeed Dying, but Not Next Week
5
Esperion Therapeutics Showing Volatility Leading into Clinical Trial Announcement